In This Issue:
Introduction; The World of Yesterday; Cracks in the System Widen; A Rumble on the Mountain - 1. Reimbursement for genetic laboratory tests and 2. Handling of high-value genomic tests; What May Happen Next - 1. Will genomic tests move to the physician fee schedule? No. and 2. Will CMS use the new genetic codes in 2012? No. and 3. Will the AMA Coding Process Consider IVDMIAs? Uncertain.
The core set of genetic test codes used by U.S. insurers and Medicare date to 1993. Only general information is conveyed by these codes to insurers – “DNA probe x 2.” They lead to payment for genetic tests based on a fixed price per genetic test step (such as “DNA probe x 2” or “DNA amplification x 3”). The payment was set using rules for the Medicare clinical laboratory fee schedule, rules which date to 1984.
Please see full issue below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.